readthroughSign in
CompanyCNTXNasdaqPhiladelphia, PA

Context Therapeutics Inc.

Context Therapeutics develops T cell-engaging bispecific antibodies for solid tumors.

8-KNov 10Latest SEC filing
Nov 9Latest story